Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1999 1
2000 4
2001 3
2002 10
2003 8
2004 3
2005 10
2006 8
2007 5
2008 6
2009 10
2010 3
2011 9
2013 3
2014 7
2015 6
2016 2
2017 2
2018 5
2019 2
2020 4
2021 5
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

119 results

Results by year

Filters applied: . Clear all
Page 1
Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease.
O'Donoghue ML, Rosenson RS, Gencer B, López JAG, Lepor NE, Baum SJ, Stout E, Gaudet D, Knusel B, Kuder JF, Ran X, Murphy SA, Wang H, Wu Y, Kassahun H, Sabatine MS; OCEAN(a)-DOSE Trial Investigators. O'Donoghue ML, et al. Among authors: lepor ne. N Engl J Med. 2022 Nov 17;387(20):1855-1864. doi: 10.1056/NEJMoa2211023. Epub 2022 Nov 6. N Engl J Med. 2022. PMID: 36342163 Free article. Clinical Trial.
Class effects of SGLT2 inhibitors on cardiorenal outcomes.
Kluger AY, Tecson KM, Lee AY, Lerma EV, Rangaswami J, Lepor NE, Cobble ME, McCullough PA. Kluger AY, et al. Among authors: lepor ne. Cardiovasc Diabetol. 2019 Aug 5;18(1):99. doi: 10.1186/s12933-019-0903-4. Cardiovasc Diabetol. 2019. PMID: 31382965 Free PMC article. Review.
Cardiovascular research.
Lepor NE. Lepor NE. Rev Cardiovasc Med. 2014;15(1):3p preceding 1. Rev Cardiovasc Med. 2014. PMID: 24822280 No abstract available.
Efficacy and safety of alirocumab in reducing lipids and cardiovascular events.
Robinson JG, Farnier M, Krempf M, Bergeron J, Luc G, Averna M, Stroes ES, Langslet G, Raal FJ, El Shahawy M, Koren MJ, Lepor NE, Lorenzato C, Pordy R, Chaudhari U, Kastelein JJ; ODYSSEY LONG TERM Investigators. Robinson JG, et al. Among authors: lepor ne. N Engl J Med. 2015 Apr 16;372(16):1489-99. doi: 10.1056/NEJMoa1501031. Epub 2015 Mar 15. N Engl J Med. 2015. PMID: 25773378 Free article. Clinical Trial.
The emergence of cardiodiabetology.
Rosenblit PD, Lepor NE, Wong ND. Rosenblit PD, et al. Among authors: lepor ne. Cardiovasc Endocrinol. 2017 Feb 15;6(1):3-7. doi: 10.1097/XCE.0000000000000117. eCollection 2017 Mar. Cardiovasc Endocrinol. 2017. PMID: 31646112 Free PMC article. Review. No abstract available.
Chemotherapy and cardiotoxicity.
Broder H, Gottlieb RA, Lepor NE. Broder H, et al. Among authors: lepor ne. Rev Cardiovasc Med. 2008 Spring;9(2):75-83. Rev Cardiovasc Med. 2008. PMID: 18660728 Free PMC article. Review.
Anorexigen-related cardiopulmonary toxicity.
Gross SB, Lepor NE. Gross SB, et al. Among authors: lepor ne. Rev Cardiovasc Med. 2000 Fall;1(2):80-9, 102. Rev Cardiovasc Med. 2000. PMID: 12457145 Review.
119 results